These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22431963)

  • 21. Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.
    Roerink ME; Knoop H; Bredie SJ; Heijnen M; Joosten LA; Netea MG; Dinarello CA; van der Meer JW
    Trials; 2015 Oct; 16():439. PubMed ID: 26438161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial.
    Sulheim D; Fagermoen E; Winger A; Andersen AM; Godang K; Müller F; Rowe PC; Saul JP; Skovlund E; Øie MG; Wyller VB
    JAMA Pediatr; 2014 Apr; 168(4):351-60. PubMed ID: 24493300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lacasa M; Alegre-Martin J; Sentañes RS; Varela-Sende L; Jurek J; Castro-Marrero J
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
    Fluge Ø; Risa K; Lunde S; Alme K; Rekeland IG; Sapkota D; Kristoffersen EK; Sørland K; Bruland O; Dahl O; Mella O
    PLoS One; 2015; 10(7):e0129898. PubMed ID: 26132314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study.
    Rekeland IG; Fosså A; Lande A; Ktoridou-Valen I; Sørland K; Holsen M; Tronstad KJ; Risa K; Alme K; Viken MK; Lie BA; Dahl O; Mella O; Fluge Ø
    Front Med (Lausanne); 2020; 7():162. PubMed ID: 32411717
    [No Abstract]   [Full Text] [Related]  

  • 27. Discordant biological and toxicological species responses to TLR3 activation.
    Mitchell WM; Nicodemus CF; Carter WA; Horvath JC; Strayer DR
    Am J Pathol; 2014 Apr; 184(4):1062-1072. PubMed ID: 24486326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Collatz A; Johnston SC; Staines DR; Marshall-Gradisnik SM
    Clin Ther; 2016 Jun; 38(6):1263-1271.e9. PubMed ID: 27229907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Placental Extract as a Subcutaneous Injection Is Effective in Chronic Fatigue Syndrome: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.
    Park SB; Kim KN; Sung E; Lee SY; Shin HC
    Biol Pharm Bull; 2016 May; 39(5):674-9. PubMed ID: 26911970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome.
    Forsyth LM; Preuss HG; MacDowell AL; Chiazze L; Birkmayer GD; Bellanti JA
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):185-91. PubMed ID: 10071523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.
    Saxena M; Sabado RL; La Mar M; Mohri H; Salazar AM; Dong H; Correa Da Rosa J; Markowitz M; Bhardwaj N; Miller E
    Front Immunol; 2019; 10():725. PubMed ID: 31024557
    [No Abstract]   [Full Text] [Related]  

  • 34. A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.
    McDermott C; Richards SC; Thomas PW; Montgomery J; Lewith G
    QJM; 2006 Jul; 99(7):461-8. PubMed ID: 16809351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA drug therapy acting via the 2-5A synthetase/RNase L pathway.
    Suhadolnik RJ; Reichenbach NL; Hitzges PM; Ablashi DV; Strayer DR; Carter WA
    Ann N Y Acad Sci; 1993 Jun; 685():756-7. PubMed ID: 8363281
    [No Abstract]   [Full Text] [Related]  

  • 36. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.
    O'Dowd H; Gladwell P; Rogers CA; Hollinghurst S; Gregory A
    Health Technol Assess; 2006 Oct; 10(37):iii-iv, ix-x, 1-121. PubMed ID: 17014748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell-Mediated T-Cell Responses.
    van Eijck CWF; Haddaoui HE; Kucukcelebi S; Vadgama D; Fellah A; Mustafa DAM; Aerts JGJV; van Eijck CHJ; Willemsen M
    Clin Cancer Res; 2024 Aug; 30(16):3447-3458. PubMed ID: 38488815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
    Toogood PL; Clauw DJ; Phadke S; Hoffman D
    Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of mast cell toll-like receptor 3 in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Systemic Mastocytosis using the novel application of autoMACS magnetic separation and flow cytometry.
    Balinas C; Nguyen T; Johnston S; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2018 Dec; 36(4):257-264. PubMed ID: 29223146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Submaximal exercise testing with near-infrared spectroscopy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients compared to healthy controls: a case-control study.
    Miller RR; Reid WD; Mattman A; Yamabayashi C; Steiner T; Parker S; Gardy J; Tang P; Patrick DM
    J Transl Med; 2015 May; 13():159. PubMed ID: 25990639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.